Shareholders Equity: The sum of preferred and common equity items.
Adverum Biotechnologies, Inc. (ADVM) had Shareholders Equity of $83.47M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$3.60M |
|
$-117.17M |
|
-- |
|
$3.60M |
|
$127.59M |
|
$-123.99M |
|
$5.75M |
|
$-118.24M |
|
$-118.24M |
|
$-117.17M |
|
$-117.17M |
|
$-117.17M |
|
$-117.17M |
|
$-123.99M |
|
$-120.28M |
|
10.08M |
|
10.08M |
|
$-11.60 |
|
$-11.60 |
|
| Balance Sheet Financials | |
$102.77M |
|
$14.76M |
|
$70.24M |
|
$173.01M |
|
$24.91M |
|
-- |
|
$64.63M |
|
$89.54M |
|
$83.47M |
|
$83.47M |
|
|
Shareholders Equity |
$83.47M |
10.14M |
|
| Cash Flow Statement Financials | |
$-90.90M |
|
$96.88M |
|
$0.07M |
|
$70.93M |
|
$76.98M |
|
$6.04M |
|
$17.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3444.20% |
|
-3444.20% |
|
-3341.17% |
|
-3284.53% |
|
-3254.58% |
|
$-91.71M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-140.37% |
|
-140.37% |
|
-67.72% |
|
-140.37% |
|
$8.23 |
|
$-9.10 |
|
$-9.02 |
|